[e-drug] WHO Drug Information

[e-drug@healthnet.org]

E-DRUG: WHO Drug Information
-----------------------------------

WHO DRUG INFORMATION highlights topics of current concern, recent regulatory
decisions and standard-setting activities, with a focus on the processes
linking regulatory activity to therapeutic practice. It presents selected
contributions portraying a variety of viewpoints from different disciplines
and pharmaceutical sciences. WHO DRUG INFORMATION can be viewed at:  
http://www.who.int/druginformation
__________________________________________________________

WHO DRUG INFORMATION, Volume 20 Number 4

In its final issue for 2006, WHO DRUG INFORMATION presents an opening
article on the emergence of extensively resistant tuberculosis and the
current status of TB medicines development by leading research institutions.
Sharing the spotlight in this issue, an authored study proposes an increased
role for prescribed and defined daily doses in the rational use of medicines
and provides an example of how this has enhanced the collection and
evaluation of data for asthma and COPD medicines.

Topics of Current Interest describes latest efforts to provide essential
medicines through the establishment of several partnerships and initiatives,
while WHO and UNICEF are making progress through implementation of their
strategy to improve access to paediatric medicines.

Extensive information is provided in the section on Safety and Efficacy
Issues concerning the latest signals, reports of adverse drug reactions, and
labeling changes. This is complemented by Regulatory Action and News which
provides the most recent decisions from regulatory authorities around the
world having a particular impact on the international provision and movement
of medicinal products.

The issue is completed with summaries of Recent Publications, Information
and Events considered of interest to readers, and concludes with Proposed
INN List 96. ____________________________________________________________